Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2017

Sep 13, 2017

30198_dirs_2017-09-13_263ff50c-2924-4e9c-95e6-6fa58c375181.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-09-11

Reporting Person: Murphy Patrick Michael (VP, Legal Aff & Chf Compl Ofcr)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-11 Common Stock D 1322 $71.8134 Disposed 33131 Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 23,092 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 7,500 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018.